• In recent days, United States Antimony Corporation announced that its Chairman and CEO, Gary C. Evans, appeared on Bloomberg Television’s Businessweek Daily to discuss a new joint venture tied to the company’s expanding critical minerals operations across the U.S., Mexico, and Canada. This comes as the company has grown into a roughly US$1.08 billion producer and processor of antimony, zeolite, and other critical minerals, highlighting how business expansion can compound investor outcomes over long periods.
• Beyond the media appearance, the company’s joint venture announcement and new mining claims in Montana, Alaska, and Ontario point to an effort to widen its production base and diversify ore sources, which could influence expectations around long-term supply security and operational scale.
• We’ll now examine how the new joint venture and North American claim expansion might reshape United States Antimony’s existing investment narrative.

Find 51 companies with promising cash flow potential yet trading below their fair value.

United States Antimony Investment Narrative Recap

To own United States Antimony, you have to believe in its role as a producer of critical minerals and its ability to turn recent capacity and footprint expansion into sustainable profitability. The new joint venture and fresh North American claims fit that thesis but do not, on their own, remove near term execution risks around permitting timelines, cost control, and the company’s still unprofitable operations.

The Bloomberg-featured joint venture tied to US Antimony’s U.S., Mexico, and Canada operations is the clearest recent development linked to future production scale and supply security. How effectively this venture supports higher utilization of existing assets and mitigates ore sourcing risks will matter for whether the company’s expansion spending can translate into improved earnings and more stable cash flows.

Yet, despite the growth story, investors should also be aware of the ongoing risk that multi year permitting delays could...

United States Antimony's narrative projects $208.1 million revenue and $82.5 million earnings by 2028. This requires 100.7% yearly revenue growth and an earnings increase of about $83.4 million from -$0.9 million today.

Uncover how United States Antimony's forecasts yield a $9.67 fair value, a 19% upside to its current price.

Exploring Other Perspectives

Nineteen fair value estimates from the Simply Wall St Community span a wide band, from US$1.28 up to US$41 per share, reflecting sharply different expectations. Set against this, the company’s unprofitable status and heavy reliance on successful project permitting remind you to weigh these views against the real risk that some planned capacity may never reach full production.

Explore 19 other fair value estimates on United States Antimony - why the stock might be worth over 5x more than the current price!

Build Your Own United States Antimony Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your United States Antimony research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
• Our free United States Antimony research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate United States Antimony's overall financial health at a glance.

Ready To Venture Into Other Investment Styles?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

• The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 26 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
• Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 31 best rare earth metal stocks of the very few that mine this essential strategic resource.
• AI is about to change healthcare. These 27 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.